The heterozygous NUDT15 variant is not associated with the severity of 6-mercaptopurine-related side effects in early intensification therapy for childhood acute lymphoblastic leukemia

Jimei Zhao,Masahiro Ueki,Saori Sawai,Minako Sugiyama,Yukayo Terashita,Shinsuke Hirabayashi,Yuko Cho,Ryoji Kobayashi,Yoichi Tanaka,Atsushi Manabe

EJC Paediatric Oncology（2023）

引用 0|浏览14

暂无评分

摘要

Clinical data and the NUDT15 variant of each patient in the early intensification phase of the treatment for ALL. Leukocyte count (A), neutrophil count (B), platelet transfusions (C) and red blood cell transfusion (D).Image 1

查看译文

关键词

Leukemia,Children,NUDT15,Mercaptopurine,Side effects

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要